Drug Pricing Investigation By Department Of Justice Requested - Rep. Coburn

19 Jun 2000

• By The Pink Sheet

The pharmaceutical industry's pricing practices for chemically similar brand name drugs merits federal investigation, Rep. Coburn (R-Okla.) said in a June 15 letter to U.S. Attorney General Reno.

Drug Pricing Investigation By Department Of Justice Requested - Rep. Coburn

More from Archive

More from Pink Sheet